FINWIRES — Financial News

Truist Raises Price Target on MGM Resorts International to $42 From $39, Keeps Hold Rating

MGM Resorts International (MGM) has an average rating of overweight and mean price target of $43.94 according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)Price: $38.42, Change: $-0.85, Percent Change: -2.16%

Financial News · Live Terminal

Truist Raises Price Target on MGM Resorts International to $42 From $39, Keeps Hold Rating

UBS Adjusts Element Solutions Price Target to $52 From $43, Maintains Buy Rating

BNP Paribas Adjusts Price Target on Ingersoll Rand to $82 From $94

Mizuho Adjusts Price Target on Humana to $290 From $258

Jefferies Adjusts Price Target on Humana to $290 From $235

Berenberg Raises Price Target on KLA Corp. to $2,000 From $1,770, Keeps Buy Rating

UBS Adjusts Amphenol Price Target to $178 From $170, Maintains Buy Rating

Cantor Fitzgerald Adjusts Price Target on Humana to $264 From $201

Barclays Adjusts Price Target on Humana to $180 From $176

Evercore ISI Adjusts Price Target on Humana to $250 From $195

Belden Shares Fall After Posting Q1 Results, Q2 Guidance

Truist Raises Price Target on Humana to $270 From $220, Keeps Hold Rating

Frontdoor Shares Drop After Q1 Adjusted Earnings, Revenue Increase

Builders FirstSource Shares Decline After Q1 Adjusted Earnings, Net Sales Fall

UBS Adjusts Automatic Data Processing Price Target to $218 From $210, Maintains Neutral Rating

Guggenheim Adjusts Price Target on Humana to $269 From $252

Hilton Grand Vacations Shares Rise After Q1 Results Beat Estimates

Guggenheim Adjusts Price Target on Biogen to $260 From $246

BofA Securities Adjusts Price Target on Alphabet to $430 From $370, Maintains Buy Rating

Goldman Sachs Adjusts Price Target on Biogen to $250 From $238

Truist Raises Price Target on MGM Resorts International to $42 From $39, Keeps Hold Rating

UBS Adjusts Element Solutions Price Target to $52 From $43, Maintains Buy Rating

BNP Paribas Adjusts Price Target on Ingersoll Rand to $82 From $94

Mizuho Adjusts Price Target on Humana to $290 From $258

Jefferies Adjusts Price Target on Humana to $290 From $235

Berenberg Raises Price Target on KLA Corp. to $2,000 From $1,770, Keeps Buy Rating

UBS Adjusts Amphenol Price Target to $178 From $170, Maintains Buy Rating

Cantor Fitzgerald Adjusts Price Target on Humana to $264 From $201

Barclays Adjusts Price Target on Humana to $180 From $176

Evercore ISI Adjusts Price Target on Humana to $250 From $195

Belden Shares Fall After Posting Q1 Results, Q2 Guidance

Truist Raises Price Target on Humana to $270 From $220, Keeps Hold Rating

Frontdoor Shares Drop After Q1 Adjusted Earnings, Revenue Increase

Builders FirstSource Shares Decline After Q1 Adjusted Earnings, Net Sales Fall

UBS Adjusts Automatic Data Processing Price Target to $218 From $210, Maintains Neutral Rating

Guggenheim Adjusts Price Target on Humana to $269 From $252

Hilton Grand Vacations Shares Rise After Q1 Results Beat Estimates

Guggenheim Adjusts Price Target on Biogen to $260 From $246

BofA Securities Adjusts Price Target on Alphabet to $430 From $370, Maintains Buy Rating

Goldman Sachs Adjusts Price Target on Biogen to $250 From $238